New Standard of Care for Early dMMR/MSI-H Colorectal Cancer? New Standard of Care for Early dMMR/MSI-H Colorectal Cancer?
Another study shows good results with neoadjuvant immunotherapy in patients with locally advanced dMMR/MSI-H colorectal cancer, leading the authors to suggest it as a new standard of care.Medscape Medical News
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Colorectal Cancer | Gastroenterology | Hematology | Immunotherapy | Neoadjuvant Therapy | Study